{u'keywords': [u'committee', u'therapeutic goods', u'Poisons Standard', u'orlistat', u'decision', u'public health', u'advertising', u'appendix', u'act', u'Appendix H.', u'th meeting', u'poisons schedule committee', u'substance', u'current Poisons Standard', u'public health benefit', u'matters', u'Appendix H listing', u'direct-to-consumer advertising', u'entry     ORLISTAT     OPTION', u'Roche', u'Therapeutic Goods Advertising', u'therapeutic goods act', u'jurisdictional members', u'Goods Advertising Code', u'Australian Idol', u'Delete entry     Orlistat', u'consumer advertising', u'Australian Capital Territory', u'RG Capital Radio', u'agenda paper', u'broad policy considerations', u'orlistat product', u'Committee meeting', u'record', u'ADJR Act', u'reg', u'reg 42ZCS', u'National Co-ordinating Committee', u'regulations', u'Committee member', u'Poisons Act', u'body mass index', u'Committee records', u'decisions', u'New Zealand', u'New Zealand Government.', u'account', u'scheduling', u'insufficient public health', u'Australian Health Ministers'], u'casename': u'Roche Products Pty Limited v National Drugs and Poisons Schedule Committee [2007] FCA 1352 (30 August 2007)', u'filename': u'training_data/07_1352.xml'}